John M. Holliman, III
2017
In 2017, John M. Holliman, III earned a total compensation of $106K as Executive Chairman Principal Executive Officer at Capstone Therapeutics, a 93% increase compared to previous year.
Compensation breakdown
| Salary | $106,000 |
|---|---|
| Total | $106,000 |
Holliman received $106K in salary, accounting for 100% of the total pay in 2017.
Rankings
In 2017, John M. Holliman, III's compensation ranked 14,418th out of 14,666 executives tracked by ExecPay. In other words, Holliman earned more than 1.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,418 out of 14,666 | 2nd |
Division Manufacturing | 5,671 out of 5,770 | 2nd |
Major group Chemicals And Allied Products | 2,035 out of 2,074 | 2nd |
Industry group Drugs | 1,692 out of 1,730 | 2nd |
Industry Pharmaceutical Preparations | 1,300 out of 1,329 | 2nd |
Source: SEC filing on July 10, 2019.
Holliman's colleagues
We found two more compensation records of executives who worked with John M. Holliman, III at Capstone Therapeutics in 2017.